Market Size in 2021 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 18.93 Billion | USD 36.84 Billion | 7.82% | 2021 |
FrequentlyAsked Questions
The major factors influencing the growth of the global high-throughput screening market include an increase in investment by governments, research institutes, and pharmaceutical companies for drug discovery & development, a rise in the prevalence of chronic diseases, and a surge in the number of drug targets for screening.
According to the report, the global high-throughput screening market was worth around USD 18.93 Billion in 2021 and is projected to grow around USD 36.84 Billion by 2030, with a compounded annual growth rate of (CAGR) of roughly 7.82% from 2022 to 2030.
The global high-throughput screening market is expected to be driven by the North American region. This is mainly due to the robust commercialization of pharmaceutical & biotechnology research and remarkable technological advancements in the region.
The major players of the global high-throughput screening market include Agilent Technologies, Inc, Danaher Corporation, Perkinelmer, Inc. Thermo Fisher Scientific Inc, Axxam S.P.A, Tecan Group Ltd, Bio-Rad Laboratories, Inc., Hamilton Company, Sigma-Aldrich Corporation, Charles River Laboratories International, Inc., Merck KGaA, Corning Incorporated, BioTek Instruments, Inc., Aurora Biomed Inc., General Electric, Beckman Coulter, Inc., Luminex Corporation, AstraZeneca, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed